Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
